ExploreWatchlistsPricing
  1. JP-listed companies
  2. Mochida Pharmaceutical Co.,Ltd.
  3. Financials
  4. Cash from operations

Mochida Pharmaceutical Co.,Ltd. (4534)

Market cap
¥123.4B
P/E ratio
14.3x
A Japanese pharmaceutical company that develops and sells prescription drugs and healthcare products through a network of manufacturing and sales subsidiaries.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndCash from operations (Million JPY)YoY (%)
Mar 31, 20259,354-225.05%
Mar 31, 2024-7,480-202.51%
Mar 31, 20237,297-2.17%
Mar 31, 20227,459-18.91%
Mar 31, 20219,198-1.59%
Mar 31, 20209,347-25.61%
Mar 31, 201912,565+282.73%
Mar 31, 20183,283-41.20%
Mar 31, 20175,583-63.30%
Mar 31, 201615,211+196.97%
Mar 31, 20155,122

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat